(Q46753178)

24 December 2017

title

Histological study of the effect of pre-transplant chemoembolization of hepatocellular carcinoma (English)

1 reference

24 December 2017

author name string

L J Zurera

1

1 reference

24 December 2017

M Canis

2

1 reference

24 December 2017

T Marchal

3

1 reference

24 December 2017

J García-Revillo

4

1 reference

24 December 2017

J M Martos

5

1 reference

24 December 2017

A Benito

6

1 reference

24 December 2017

E Fraga

7

1 reference

24 December 2017

language of work or name

Spanish

0 references

publication date

1 January 2008

1 reference

24 December 2017

published in

Radiología

1 reference

24 December 2017

volume

50

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

47-53

1 reference

24 December 2017

Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Liver Transplantation for Malignant Diseases: Selection andPattern of Recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-8338%2808%2971928-3

7 January 2021

10.1016/S0033-8338(08)71928-3

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017